Macquarie Group LTD 10x Genomics, Inc. Transaction History

Macquarie Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$28.48 - $52.59 $2.18 Million - $4.02 Million	-76,524 Closed	0 $25,000
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $2.04 Million - $4.56 Million	-55,293 Reduced 41.95%	76,524 $3.46 Million
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $3.25 Million - $8.51 Million	58,401 Added 79.55%	131,817 $11.9 Million
Q4 2021 Feb 11, 2022	SELL	$135.05 - $182.59 $68.3 Million - $92.3 Million	-505,524 Reduced 87.32%	73,416 $10.9 Million
Q3 2021 Nov 12, 2021	SELL	$145.58 - $192.14 $637,785 - $841,765	-4,381 Reduced 0.75%	578,940 $84.3 Million
Q2 2021 Aug 13, 2021	BUY	$134.22 - $202.37 $14.2 Million - $21.4 Million	105,609 Added 22.11%	583,321 $114 Million
Q1 2021 May 14, 2021	BUY	$140.25 - $196.86 $67 Million - $94 Million	477,712 New	477,712 $86.5 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.